Business Context and Reporting Period
Company: Actuant Corporation (formerly Applied Power Inc.)
Filing Type: Form 10-K (Annual Report)
Period Ended: August 31, 2001
Business Overview: Actuant is a global manufacturer of industrial products organized into two segments: Tools & Supplies (specialized electrical and industrial tools, including Enerpac and Gardner Bender brands) and Engineered Solutions (customized motion control systems for OEMs in RV, truck, and automotive markets).
Key Corporate Event: The company completed a spin-off of its Electronics Business (APW Ltd.) on July 31, 2000. The fiscal 2001 results reflect the post-spin-off industrial operations only.
Key Financial Metrics (Fiscal Year 2001)
| Metric | Value (in millions) |
|---|---|
| Net Sales | $481.9 |
| Gross Profit | $168.9 |
| Gross Margin | 35.0% |
| Operating Earnings | $71.9 |
| Earnings from Continuing Operations | $24.4 |
| Diluted EPS (Continuing Ops) | $2.93 |
| Cash Flow from Operations | $95.1 |
| Total Debt | $327.5 |
| Net Financing Costs | $49.2 |
| Capital Expenditures | $6.7 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 29.3% to $481.9 million from $681.4 million in fiscal 2000. This decline is primarily attributed to the divestiture of non-continuing businesses (Barry Controls, Air Cargo, etc.) in fiscal 2000. On an adjusted basis (excluding divestitures), sales decreased 7.6% due to unfavorable currency translation ($14.1 million impact) and weaker economic conditions.
- Profitability: Operating earnings declined to $71.9 million from $89.7 million. Adjusted operating earnings (excluding non-continuing businesses) increased slightly to $66.7 million from $63.1 million in fiscal 2000.
- Debt Reduction: Total debt decreased by $105 million during fiscal 2001, reducing the balance from $432.6 million to $327.5 million. The company utilized cash from operations and divestitures (Mox-Med and QMC) to pay down debt.
- Acquisitions & Divestitures: Acquired Dewald Manufacturing (RV systems) for $13.0 million. Divested Mox-Med (gain of $18.5 million) and Quick Mold Change (loss of $0.7 million).
Guidance, Outlook, and Risks
Management Outlook (Fiscal 2002)
- Revenue: Expected to range from $450 million to $480 million.
- EBITDA: Expected to range from $85 million to $93 million.
- Diluted EPS: Expected to range from $2.50 to $3.00.
- Debt Reduction: Anticipated reduction of $25-30 million, excluding divestitures/acquisitions.
- Tax Rate: Expected effective tax rate of approximately 37.0%, lower than fiscal 2001 due to SFAS No. 142 adoption (non-amortization of goodwill) and higher utilization of foreign tax credits.
Risks and Contingencies
- High Leverage: The company maintains high debt levels, resulting in less financial flexibility and strict debt covenants. Net financing costs remain high ($49.2 million) due to the 13% Senior Subordinated Notes.
- Economic Sensitivity: Results are sensitive to economic conditions in the recreational vehicle, trucking, automotive, and construction industries.
- Foreign Currency: Significant international operations (25% of sales from Europe) expose the company to exchange rate fluctuations.
- Legal/Environmental: The company faces various legal proceedings and environmental remediation liabilities (accruals of $2.1 million), though management does not expect a material adverse effect.
- Dividend Policy: No dividends are expected in the foreseeable future; cash flow is prioritized for debt reduction.
Investor Verification Checklist
- Adjusted vs. Reported Metrics: Verify the distinction between reported results (which include divested businesses in prior years) and "adjusted" results (continuing operations only) to accurately assess organic growth trends.
- Debt Service Capacity: Confirm the company's ability to service $327.5 million in debt, particularly the high-interest 13% notes, given the reliance on operating cash flow for principal reduction.
- Currency Impact: Assess the sensitivity of future earnings to the Euro and other foreign currency fluctuations, as translation impacts were significant in fiscal 2001.
- Divestiture Proceeds: Verify the utilization of the $40.5 million gain from the Mox-Med sale and ensure it was applied to debt reduction as stated.
- Goodwill Accounting: Monitor the impact of the new SFAS No. 142 standard (adopted Sept 1, 2001) which eliminates goodwill amortization, expected to increase net income by ~$3.2 million in fiscal 2002.